Published in
Taylor and Francis Group, Leukemia & Lymphoma, 9(61), p. 2277-2279, 2020
DOI: 10.1080/10428194.2020.1759049
Links
Tools
Efficacy of venetoclax based salvage chemotherapy followed by “Minimal Residual Disease driven”-venetoclax maintenance therapy post-allotransplant in a young patient with high risk primary refractory acute myeloid leukemia
Journal article published in 2020 by
Elisabetta Todisco,
Federica Gigli,
Simona Sammassimo,
Chiara Camisaschi 
,
Patrizia Mancuso,
Chiara Ronchini ,
Safaa Ramadan,
Francesco Bertolini,
Rocco Pastano,
Corrado Tarella
,
Patrizia Mancuso,
Chiara Ronchini ,
Safaa Ramadan,
Francesco Bertolini,
Rocco Pastano,
Corrado Tarella
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 